相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
Douglas J. Schwartzentruber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15
Lazar Vujanovic et al.
BLOOD (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus
Lazar Vujanovic et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Expression Hierarchy of T Cell Epitopes from Melanoma Differentiation Antigens: Unexpected High Level Presentation of Tyrosinase-HLA-A2 Complexes Revealed by Peptide-Specific, MHC-Restricted, TCR-Like Antibodies
Yael Michaeli et al.
JOURNAL OF IMMUNOLOGY (2009)
Dominant Role of Antigen Dose in CD4+Foxp3+ Regulatory T Cell Induction and Expansion
Michael S. Turner et al.
JOURNAL OF IMMUNOLOGY (2009)
Helper T-Cell Responses and Clinical Activity of a Melanoma Vaccine With Multiple Peptides From MAGE and Melanocytic Differentiation Antigens
Craig L. Slingluff et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Adenovirus MART-1 - engineered autologous dendritic cell vaccine for metastatic melanoma
Lisa H. Butterfield et al.
JOURNAL OF IMMUNOTHERAPY (2008)
A mycoplasma peptide elicits heteroclitic CD4 T cell responses against tumor antigen MAGE-A6
Lazar Vujanovic et al.
CLINICAL CANCER RESEARCH (2007)
AFP-specific CD4+ helper T-cell responses in healthy donors and HCC patients
Viktoria N. Evdokimova et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA
J. A. Kyte et al.
CANCER GENE THERAPY (2006)
Adenoviral vector platform for transduction of constitutive and regulated tricistronic or triple-transcript transgene expression in mammalian cells and microtissues
Valeria Gonzalez-Nicolini et al.
JOURNAL OF GENE MEDICINE (2006)
Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity
Anna K. Palucka et al.
JOURNAL OF IMMUNOTHERAPY (2006)
IFN-α-conditioned dendritic cells are highly efficient in inducing cross-priming CD8+ T cells against exogenous viral antigens
Caterina Lapenta et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents
Martin Monte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Hierarchy of a fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancer
Yang Liu et al.
JOURNAL OF IMMUNOLOGY (2006)
Direct stimulation of T cells by type IIFN enhances the CD8+ T cell response during cross-priming
Agnes Le Bon et al.
JOURNAL OF IMMUNOLOGY (2006)
Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cells
JA Wargo et al.
CANCER GENE THERAPY (2005)
Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy
PH Tan et al.
BLOOD (2005)
Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity
YK He et al.
JOURNAL OF IMMUNOLOGY (2005)
Langerhans cells derived from genetically modified human CD34+hemopoietic progenitors are more potent than peptide-pulsed Langerhans cells for inducing antigen-specific CD8+ cytolytic T lymphocyte responses
J Yuan et al.
JOURNAL OF IMMUNOLOGY (2005)
Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: Comparison with immunodominant peptide-pulsed DCs
M Nakamura et al.
ONCOLOGY (2005)
Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy
A Ribas et al.
JOURNAL OF IMMUNOTHERAPY (2004)
Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cells
S Mehrotra et al.
IMMUNOLOGY (2004)
Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T-cell responses
L Schumacher et al.
JOURNAL OF IMMUNOTHERAPY (2004)
Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon
A Le Bon et al.
NATURE IMMUNOLOGY (2003)
Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients
RL Mandelcorn-Monson et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Molecular and functional bases of self-antigen recognition in long-term persistent melanocyte-specific CD8+ T cells in one vitiligo patient
S Mantovani et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy
MJ Scanlan et al.
IMMUNOLOGICAL REVIEWS (2002)
Disease-associated bias in T helper type 1 (Th1)/Th2 CD4+ T cell responses against MAGE-6 in HLA-DRB1*0401+ patients with renal cell carcinoma or melanoma
T Tatsumi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Hypopigmentation associated with an adenovirus-mediated gp100/MART-1-transduced dendritic cell vaccine for metastatic melanoma
H Tsao et al.
ARCHIVES OF DERMATOLOGY (2002)
Reciprocal activating interaction between natural killer cells and dendritic cells
F Gerosa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and Gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers:: the role of cellular immunity in the etiopathogenesis of vitiligo
B Palermo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
HLA-A2 restricted, melanocyte-specific CD8+ T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1
KS Lang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: Preclinical studies in myeloma
XY Wen et al.
CANCER GENE THERAPY (2001)
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population
K Imai et al.
LANCET (2000)
Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells
A Ribas et al.
JOURNAL OF IMMUNOTHERAPY (2000)
分享论文
